Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-12-28 Lurker Nancy Executive Vice Chair Gift +52,208 52,208
2023-12-28 Lurker Nancy Executive Vice Chair Gift · Stock Option (Right to Buy) −31,164 62,330
2023-12-28 Lurker Nancy Executive Vice Chair Gift · Stock Option (Right to Buy) +31,164 151,370
2023-12-28 Lurker Nancy Executive Vice Chair Gift · Stock Option (Right to Buy) −10,906 4,674
2023-12-28 Lurker Nancy Executive Vice Chair Gift · Stock Option (Right to Buy) +10,906 70,126
2023-12-28 Lurker Nancy Executive Vice Chair Gift · Stock Option (Right to Buy) −35,000 130,000
2023-12-28 Lurker Nancy Executive Vice Chair Gift · Stock Option (Right to Buy) +35,000 110,000
2023-12-28 Lurker Nancy Executive Vice Chair Gift · Stock Option (Right to Buy) −31,164 62,330
2023-12-28 Lurker Nancy Executive Vice Chair Gift · Stock Option (Right to Buy) +31,164 151,370
2023-12-28 Lurker Nancy Executive Vice Chair Gift · Stock Option (Right to Buy) −10,906 4,674
2023-12-28 Lurker Nancy Executive Vice Chair Gift · Stock Option (Right to Buy) +10,906 70,126
2023-12-28 Lurker Nancy Executive Vice Chair Gift · Stock Option (Right to Buy) −35,000 130,000
2023-12-28 Lurker Nancy Executive Vice Chair Gift · Stock Option (Right to Buy) +35,000 110,000
2023-12-13 Paggiarino Dario A. Chief Medical Officer Option exercise 10b5-1 +1,458 $10.13 $15K 27,165
2023-12-13 Paggiarino Dario A. Chief Medical Officer Sale 10b5-1 −1,458 $20.00 $29K 25,707
2023-12-13 Paggiarino Dario A. Chief Medical Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −1,458 37,917
2023-12-08 Cormorant Asset Management, LP 10% owner Purchase +588,235 $17.00 $10.0M 6,038,235
2023-12-06 Ocumension Therapeutics Director Sale −266,242 $18.41 $4.9M 2,010,721
2023-12-06 Liu Ye Director Sale −266,242 $18.41 $4.9M 2,010,721
2023-12-05 Ocumension Therapeutics Director Sale −733,758 $19.91 $14.6M 2,276,963

Page 19 of 31 · 616 trades